169 related articles for article (PubMed ID: 12432424)
41. Onychomycosis: A study of self-recognition by patients and quality of life.
Bunyaratavej S; Pattanaprichakul P; Leeyaphan C; Chayangsu O; Bunyaratavej S; Kulthanan K
Indian J Dermatol Venereol Leprol; 2015; 81(3):270-4. PubMed ID: 25851764
[TBL] [Abstract][Full Text] [Related]
42. Achilles foot screening project: preliminary results of patients screened by dermatologists.
Roseeuw D
J Eur Acad Dermatol Venereol; 1999 Sep; 12 Suppl 1():S6-9; discussion S17. PubMed ID: 10509935
[TBL] [Abstract][Full Text] [Related]
43. Isolation of Onychocola canadensis from four cases of onychomycosis in Belgium.
Van Esbroeck M; Wuytack C; Van Looveren K; Swinne D
Acta Clin Belg; 2003; 58(3):190-2. PubMed ID: 12945479
[TBL] [Abstract][Full Text] [Related]
44. Correlation of clinical characteristics, by calculation of SCIO index, with the laboratory diagnosis of onychomycosis.
Dubljanin E; Dzamic A; Vujcic I; Mijatovic S; Crvenkov T; Grujicic SS; Calovski IC
Braz J Microbiol; 2022 Mar; 53(1):221-229. PubMed ID: 35000126
[TBL] [Abstract][Full Text] [Related]
45. The prevalence, aetiological agents and therapy of onychomycosis in patients with psoriasis: a prospective controlled trial.
Kaçar N; Ergin S; Ergin C; Erdogan BS; Kaleli I
Clin Exp Dermatol; 2007 Jan; 32(1):1-5. PubMed ID: 16824053
[TBL] [Abstract][Full Text] [Related]
46. Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison.
Sigurgeirsson B; Elewski BE; Rich PA; Opper C; Cai B; Nyirady J; Bakshi R
J Dermatolog Treat; 2006; 17(1):38-44. PubMed ID: 16467022
[TBL] [Abstract][Full Text] [Related]
47. Diagnosing onychomycosis.
Gupta AK; Ricci MJ
Dermatol Clin; 2006 Jul; 24(3):365-9. PubMed ID: 16798434
[TBL] [Abstract][Full Text] [Related]
48. [Fungal infections and nail psoriasis].
Solovăstru LG; Vâţă D
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1083-8. PubMed ID: 20191878
[TBL] [Abstract][Full Text] [Related]
49. Review of antifungal therapy and the severity index for assessing onychomycosis: part I.
Baran R; Hay RJ; Garduno JI
J Dermatolog Treat; 2008; 19(2):72-81. PubMed ID: 18484426
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years.
Sigurgeirsson B; Olafsson JH; Steinsson JT; Kerrouche N; Sidou F
J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):910-5. PubMed ID: 20028447
[TBL] [Abstract][Full Text] [Related]
51. Onychomycosis: updates and management challenges. A review.
Ayanlowo O; Oladele RO
Niger Postgrad Med J; 2014 Jun; 21(2):185-91. PubMed ID: 25167597
[TBL] [Abstract][Full Text] [Related]
52. A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis.
Havu V; Brandt H; Heikkilä H; Hollmen A; Oksman R; Rantanen T; Saari S; Stubb S; Turjanmaa K; Piepponen T
Br J Dermatol; 1997 Feb; 136(2):230-4. PubMed ID: 9068738
[TBL] [Abstract][Full Text] [Related]
53. The new oral antifungal agents for onychomycosis of the toenails.
Gupta AK; Shear NH
J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):1-13. PubMed ID: 10565624
[TBL] [Abstract][Full Text] [Related]
54. Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study.
Amichai B; Nitzan B; Mosckovitz R; Shemer A
Br J Dermatol; 2010 Jan; 162(1):46-50. PubMed ID: 19785609
[TBL] [Abstract][Full Text] [Related]
55. Total dystrophic onychomycosis caused by
Sunny N; Nair SP; Justus L; Beena A
Indian J Dermatol Venereol Leprol; 2018; 84(1):87-90. PubMed ID: 29251280
[No Abstract] [Full Text] [Related]
56. Prevalence of toe nail onychomycosis in diabetic patients.
Saunte DM; Holgersen JB; Haedersdal M; Strauss G; Bitsch M; Svendsen OL; Arendrup MC; Svejgaard EL
Acta Derm Venereol; 2006; 86(5):425-8. PubMed ID: 16955188
[TBL] [Abstract][Full Text] [Related]
57. NailQoL: a quality-of-life instrument for onychomycosis.
Warshaw EM; Foster JK; Cham PM; Grill JP; Chen SC
Int J Dermatol; 2007 Dec; 46(12):1279-86. PubMed ID: 18173524
[TBL] [Abstract][Full Text] [Related]
58. PAS is optimal for diagnosing onychomycosis.
Barak O; Asarch A; Horn T
J Cutan Pathol; 2010 Oct; 37(10):1038-40. PubMed ID: 20412344
[TBL] [Abstract][Full Text] [Related]
59. Onychomycosis: diagnosis and systemic treatment.
Milles CL; Riley PA; Kessenich CR
Nurse Pract; 1998 Dec; 23(12):40-2, 45-8, 51. PubMed ID: 9879077
[TBL] [Abstract][Full Text] [Related]
60. Proximal Subungual Onychomycosis in the Immunocompetent: A Case Report and Review of the Literature.
Liang SE; Cohen DE; Rieder EA
J Drugs Dermatol; 2018 Apr; 17(4):475-478. PubMed ID: 29601625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
